We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Merck subsidiary could lose patent protection on the popular antibiotic Cubicin next year, after a federal appellate court invalidated four of the company’s five patents on the drug. Read More
Horizon Pharma shareholders have approved the company’s issuance of more than 81.7 million new shares to help fund the Irish drugmaker’s hostile takeover of Depomed. Read More
Gilead’s Harvoni Wins Expanded Label
The Medicines Company Wins Rehearing In Patent Dispute
Independent Committee Recommends No Changes for Merck Cholesterol Drug Study
Arch Biopartners Wins Orphan Drug Designation for Pseudomonas Aeruginosa Therapy
Roche to Close Four Facilities, Cut 1,200 Jobs Read More
Mylan’s attempted hostile takeover of Perrigo ended fast and ignominiously Nov. 13, with shareholders of the Irish OTC drugmaker largely spurning the generic giant’s bid for control. Read More
The head of the World Health Organization is speaking out against the Trans Pacific Partnership, contending that the 12-country deal could cause drug prices to spike. Read More
WuXi, Lilly Partner to Develop Dyslipidemia Drug
Leo Pharma to Acquire Astellas Dermatology Business
Judge Allows Insider Trading Case Against Valeant to Proceed
Protest Outside Pfizer’s H.Q. Over Vaccine Prices Read More
India’s Central Drugs Standard Control Organization has unveiled three new guidelines that it says paves the way forward for more clinical trials in the country by reducing red tape for clinical research. Read More
The Washington Legal Foundation is asking the Supreme Court to revisit its stance on drugmakers’ liability in state tort suits over FDA-approved labeling. Read More